Gastrointestinal Pathology — MCQs

A 55-year-old woman presents with fatigue and malaise which has been worsening over the last 2 months. She also noticed loss of appetite and early satiety. Evaluation finds an ulcerative mass located along the lesser curvature of the stomach along with bilateral ovarian masses. Which of the following is this patient most likely to have?

Gastrointestinal Pathology Indian Medical PG Practice Questions and MCQs

Question 131: Which of the following statements about Barrett's Esophagus is false?

A. It is a premalignant condition.
B. It can be diagnosed by visual inspection during endoscopy.
C. Biopsy is necessary to confirm the diagnosis.
D. None of the above statements are false. (Correct Answer)

Explanation: **Explanation:** Barrett’s Esophagus (BE) is a complication of chronic Gastroesophageal Reflux Disease (GERD) characterized by **intestinal metaplasia** [1]. The normal stratified squamous epithelium of the esophagus is replaced by simple columnar epithelium with **goblet cells** to better withstand acid injury [1]. * **Option A is true:** BE is a well-established **premalignant condition**. It follows a metaplasia-dysplasia-adenocarcinoma sequence [2]. Patients with BE have a significantly increased risk (approx. 30-40 times) of developing **Esophageal Adenocarcinoma** [1]. * **Option B is true:** During endoscopy, BE appears as "tongues" of velvety, salmon-pink mucosa extending upward from the gastroesophageal junction, contrasting with the pale, smooth squamous mucosa. While visual inspection (endoscopic suspicion) is the first step, it must be validated. * **Option C is true:** Histopathological confirmation is the **gold standard** [2]. Diagnosis requires a biopsy demonstrating intestinal metaplasia (specifically the presence of **Goblet cells**) [1]. Without histological evidence, visual changes are merely termed "columnar-lined esophagus." Since all statements (A, B, and C) are medically accurate, **Option D** is the correct choice. **High-Yield Clinical Pearls for NEET-PG:** * **Most common site:** Distal third of the esophagus. * **Key Histology:** Presence of **Goblet cells** is pathognomonic for intestinal metaplasia in the esophagus [1]. * **Molecular Marker:** Overexpression of **p53** and **p16** is often seen in the progression to dysplasia. * **Surveillance:** Patients are monitored with periodic endoscopies and "Seattle protocol" biopsies (4-quadrant biopsies every 1–2 cm) [2]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Alimentary System Disease, pp. 348-349. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, pp. 764-765.

Question 132: What is the most common type of gastric carcinoma?

A. Squamous cell carcinoma
B. Adenocarcinoma (Correct Answer)
C. Lymphoma
D. Leiomyosarcoma

Explanation: **Explanation:** **Adenocarcinoma** is the most common histological type of gastric cancer, accounting for more than **90-95%** of all gastric malignancies. This is because the stomach is lined by glandular epithelium (mucosa), and cancers arising from these mucus-secreting cells are classified as adenocarcinomas. According to the **Lauren classification**, these are further divided into two main types: **Intestinal** (associated with H. pylori and intestinal metaplasia) and **Diffuse** (associated with CDH1 mutations and signet ring cells) [1]. **Analysis of Incorrect Options:** * **Squamous cell carcinoma (A):** This is extremely rare in the stomach. It typically occurs in the esophagus or the anal canal where squamous epithelium is naturally present. * **Lymphoma (C):** While the stomach is the most common site for extranodal lymphomas (specifically MALToma and Diffuse Large B-Cell Lymphoma), they only account for about 1–5% of all gastric malignancies [2]. * **Leiomyosarcoma (D):** This is a rare mesenchymal tumor arising from the smooth muscle of the gastric wall. Most mesenchymal tumors in the stomach are now reclassified as Gastrointestinal Stromal Tumors (GIST). **High-Yield Clinical Pearls for NEET-PG:** * **Risk Factors:** *H. pylori* infection (most common), smoking, high salt intake, and N-nitroso compounds. * **Virchow’s Node:** Involvement of the left supraclavicular lymph node is a classic sign of metastatic gastric cancer. * **Sister Mary Joseph Nodule:** Periumbilical metastasis, most commonly associated with gastric adenocarcinoma. * **Krukenberg Tumor:** Bilateral ovarian metastasis characterized by signet ring cells, usually originating from the stomach. * **Blood Group A:** Epidemiologically associated with an increased risk of gastric cancer. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, pp. 779-780. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Alimentary System Disease, pp. 356-357.

Question 133: The adenomatous polyps of the large bowel are most often situated in which location?

A. Ascending colon
B. Transverse colon
C. Descending colon
D. Sigmoid colon (Correct Answer)

Explanation: ### Explanation **Correct Option: D (Sigmoid colon)** Adenomatous polyps are the most common neoplastic polyps of the large bowel and are considered precursors to colorectal adenocarcinoma [1]. Statistically, the majority of these polyps (approximately 50-60%) occur in the **rectosigmoid region**, with the **sigmoid colon** being the most frequent site. This distribution mirrors the incidence of colorectal cancer, which also shows a predilection for the distal colon. **Analysis of Incorrect Options:** * **A & B (Ascending and Transverse Colon):** While the incidence of "right-sided" (proximal) lesions is increasing in older populations, these sites remain less common than the distal segments for traditional adenomatous polyps [3]. * **C (Descending Colon):** Although part of the left colon, the descending colon hosts fewer polyps compared to the sigmoid colon, which is the most common site for both pedunculated and sessile adenomas. **High-Yield Clinical Pearls for NEET-PG:** * **The Adenoma-Carcinoma Sequence:** This involves the mutation of the **APC gene** (gatekeeper), followed by *KRAS* mutations and finally *TP53* loss [2]. * **Size and Histology:** The risk of malignancy in a polyp is directly proportional to its **size** (>2 cm) and **histological architecture** (Villous > Tubulovillous > Tubular) [1]. "Villous is Villainous." * **Screening:** Because most adenomas are asymptomatic but can bleed occultly, colonoscopy is the gold standard for both detection and prophylactic removal (polypectomy) [3]. * **Familial Adenomatous Polyposis (FAP):** Characterized by >100 polyps, usually appearing in the teens; 100% risk of progress to cancer if not treated by prophylactic colectomy [2]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Alimentary System Disease, pp. 371-372. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Alimentary System Disease, pp. 372-373. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, pp. 814-815.

Question 134: Which of the following statements is false?

A. Cowden syndrome is due to PTEN mutation.
B. Gardner syndrome is due to APC mutation.
C. Turcot syndrome is due to APC mutation.
D. Cronkhite-Canada syndrome is due to SMAD-4 mutation. (Correct Answer)

Explanation: **Explanation:** The correct answer is **D** because **Cronkhite-Canada syndrome (CCS)** is a **non-hereditary (sporadic)** polyposis syndrome [1]. Unlike the other options, it is not associated with a specific germline mutation. It is characterized by hamartomatous polyps throughout the GI tract, accompanied by unique ectodermal changes such as alopecia, nail dystrophy, and hyperpigmentation. **Analysis of Options:** * **A. Cowden Syndrome:** This is an autosomal dominant disorder caused by a mutation in the **PTEN** tumor suppressor gene [1]. It presents with multiple hamartomatous polyps and carries a high risk of breast, thyroid, and endometrial cancers. * **B. Gardner Syndrome:** This is a clinical variant of Familial Adenomatous Polyposis (FAP) caused by mutations in the **APC gene**. It is characterized by the triad of colonic polyposis, osteomas (usually of the mandible), and soft tissue tumors (desmoid tumors). * **C. Turcot Syndrome:** This involves colonic polyposis plus central nervous system tumors. It is genetically heterogeneous: Type 1 is associated with DNA mismatch repair genes (HNPCC), while Type 2 is associated with **APC gene** mutations (associated with Medulloblastoma). **NEET-PG High-Yield Pearls:** * **SMAD4/BMPR1A mutations** are actually associated with **Juvenile Polyposis Syndrome (JPS)**, not Cronkhite-Canada [1]. * **Peutz-Jeghers Syndrome** is associated with **STK11 (LKB1)** mutations and presents with perioral pigmentation [1], [2]. * **Remember:** Cronkhite-Canada is **acquired** and typically occurs in older adults (age >50) [1], whereas most other polyposis syndromes are congenital. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, p. 813. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, pp. 813-814.

Question 135: The chances of a gastric carcinoma are not increased in which of the following conditions?

A. Pernicious anemia
B. Atrophic gastritis
C. Achlorhydria
D. Duodenal ulcer (Correct Answer)

Explanation: **Explanation:** The development of gastric carcinoma is strongly associated with conditions that lead to **chronic mucosal inflammation, atrophy, and intestinal metaplasia.** **Why Duodenal Ulcer is the Correct Answer:** Duodenal ulcers (DU) are primarily associated with **high gastric acid output** (hyperchlorhydria) and *H. pylori* colonization limited mostly to the antrum. High acid levels are actually "protective" against the development of gastric cancer because the malignancy thrives in an environment of low acid and mucosal atrophy. Patients with DU have a significantly lower risk of developing gastric adenocarcinoma compared to the general population. **Analysis of Incorrect Options:** * **Pernicious Anemia:** This is an autoimmune condition where antibodies destroy parietal cells, leading to profound achlorhydria and vitamin B12 deficiency [2]. The resulting chronic atrophic gastritis increases the risk of gastric carcinoid tumors and adenocarcinoma (3-fold increase) [1]. * **Atrophic Gastritis:** This is the common precursor lesion for the "intestinal type" of gastric carcinoma [3]. The loss of glandular epithelium and subsequent intestinal metaplasia provide the soil for neoplastic transformation [4]. * **Achlorhydria:** Low or absent gastric acid allows for the overgrowth of nitrate-reducing bacteria. These bacteria convert dietary nitrates into carcinogenic **N-nitroso compounds**, which are directly mutagenic to the gastric mucosa. **NEET-PG High-Yield Pearls:** * **Lauren Classification:** Gastric cancer is divided into **Intestinal type** (associated with H. pylori, atrophy, and environmental factors) and **Diffuse type** (associated with *CDH1* mutations/E-cadherin loss and Signet ring cells). * **H. pylori Paradox:** While *H. pylori* is the #1 risk factor for gastric cancer, it also causes duodenal ulcers. However, the **location** matters: *Antral-predominant* gastritis leads to DU; *Pangastritis/Body-predominant* gastritis leads to atrophy and Cancer. * **Blood Group A:** Associated specifically with an increased risk of gastric carcinoma. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Alimentary System Disease, pp. 351-352. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, pp. 772-773. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Alimentary System Disease, pp. 354-355. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, pp. 777-778.

Question 136: In which of the following conditions of malabsorption is an intestinal biopsy diagnostic?

A. Celiac disease
B. Tropical sprue
C. Whipple's disease (Correct Answer)
D. Lactose intolerance

Explanation: In malabsorption syndromes, intestinal biopsy findings are categorized into three groups: **Diagnostic** (pathognomonic), **Suggestive** (non-specific), and **Normal**. ### Why Whipple’s Disease is the Correct Answer **Whipple’s disease** is one of the few conditions where a biopsy is considered **diagnostic** [1]. The hallmark histological finding is the presence of **PAS-positive, diastase-resistant macrophages** in the lamina propria [1]. these macrophages contain the causative organism, *Tropheryma whipplei*. Electron microscopy showing "bacilliform bodies" further confirms the diagnosis [1]. ### Analysis of Incorrect Options * **Celiac Disease:** Biopsy is **suggestive but not diagnostic** [2]. Findings like villous atrophy, crypt hyperplasia, and increased intraepithelial lymphocytes (Marsh Criteria) are also seen in tropical sprue, cow's milk allergy, and viral enteritis [3]. Diagnosis requires clinical and serological correlation (anti-tTG antibodies) [4]. * **Tropical Sprue:** Similar to Celiac disease, the biopsy shows non-specific subtotal villous atrophy [5]. It is a diagnosis of exclusion based on travel history and response to antibiotics/folate. * **Lactose Intolerance:** The intestinal mucosa appears **histologically normal**. Diagnosis is typically made via a Hydrogen Breath Test or clinical challenge. ### High-Yield Clinical Pearls for NEET-PG * **Other Diagnostic Biopsies:** Abetalipoproteinemia (clear, lipid-laden enterocytes), Agammaglobulinemia (absence of plasma cells), and Amyloidosis (Congo red positive deposits). * **Whipple’s Disease Triad:** Malabsorption, migratory polyarthritis, and lymphadenopathy [1]. It can also cause CNS and cardiac (endocarditis) symptoms. * **Mnemonic for PAS-positive in GI:** "**W**hipple’s **W**ants **P**AS" (Whipple's = PAS positive). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, pp. 798-799. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Alimentary System Disease, pp. 361-362. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, pp. 789-790. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Alimentary System Disease, pp. 360-361. [5] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, pp. 790-791.

Question 137: Multiple transverse small intestinal ulcers with undermined edges are commonly found in patients of which condition?

A. Typhoid
B. Tuberculosis (Correct Answer)
C. Amoebiasis
D. Regional ileitis (Crohn's disease)

Explanation: **Explanation:** The correct answer is **Tuberculosis (B)**. In intestinal tuberculosis, the bacilli (usually *Mycobacterium tuberculosis* or *M. bovis*) typically involve the Peyer’s patches [1]. The infection spreads via the **submucosal lymphatics**, which are arranged circumferentially (transversely) around the bowel wall. As the infection progresses, the resulting necrosis leads to ulcers that follow this lymphatic distribution, appearing **transverse** to the long axis of the bowel. These ulcers characteristically have **undermined edges** because the necrotic process in the submucosa is more extensive than the overlying mucosal destruction. **Analysis of Incorrect Options:** * **Typhoid (A):** Typhoid ulcers (caused by *Salmonella typhi*) occur in the Peyer’s patches but are oriented **longitudinally** (along the long axis of the bowel). They have thin, "paper-like" edges and are prone to perforation. * **Amoebiasis (C):** *Entamoeba histolytica* causes **flask-shaped ulcers** with a narrow neck and a broad base. These are primarily found in the large intestine (cecum and colon) rather than the small intestine. * **Regional ileitis/Crohn's disease (D):** Crohn’s disease is characterized by **aphthous ulcers** that progress to deep, **serpiginous (snake-like)** or linear ulcers, often resulting in a "cobblestone" appearance [2]. **NEET-PG High-Yield Pearls:** * **Intestinal TB:** Most common site is the **Ileocecal region** [2] (due to high lymphoid tissue density and physiological stasis). * **Morphological types:** Ulcerative (common in primary TB), Hyperplastic (common in secondary TB, presents with "fleshy" thickening), and Ulcerohyperplastic. * **Healing:** TB ulcers heal by fibrosis, often leading to **strictures** (the "string sign" on barium studies) [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Infectious Diseases, pp. 384-385. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Alimentary System Disease, pp. 363-364.

Question 138: What is a highly sensitive and specific marker for detecting intestinal inflammation, as seen in ulcerative colitis?

A. C-reactive protein (CRP)
B. Fecal lactoferrin (Correct Answer)
C. Fecal calprotectin
D. Erythrocyte sedimentation rate (ESR)

Explanation: **Explanation:** The correct answer is **Fecal lactoferrin**. **1. Why Fecal Lactoferrin is Correct:** Lactoferrin is an iron-binding glycoprotein found primarily in the secondary granules of neutrophils. In inflammatory conditions like Ulcerative Colitis (UC) [1] or Crohn’s disease, neutrophils migrate to the intestinal mucosa and degranulate, releasing lactoferrin into the feces. Because it is highly resistant to proteolysis in the gut, it serves as a **highly sensitive and specific marker** for intestinal inflammation. It helps clinicians differentiate between Inflammatory Bowel Disease (IBD) and non-inflammatory conditions like Irritable Bowel Syndrome (IBS). **2. Analysis of Incorrect Options:** * **C-reactive protein (CRP) & Erythrocyte sedimentation rate (ESR):** These are systemic markers of inflammation. While they are often elevated in IBD, they lack specificity for the gastrointestinal tract and can be raised due to infections or inflammation anywhere in the body. * **Fecal calprotectin:** This is also a very strong marker for intestinal inflammation (often used interchangeably with lactoferrin in clinical practice). However, in the context of specific competitive exams like NEET-PG, if both are listed, **Fecal Lactoferrin** is traditionally highlighted in standard pathology texts (like Robbins) as a highly specific indicator of the neutrophilic infiltrate characteristic of active IBD. **3. Clinical Pearls for NEET-PG:** * **Gold Standard for Diagnosis:** Histopathology via colonoscopy remains the gold standard for UC. * **Marker of Activity:** Fecal lactoferrin levels correlate well with the severity of endoscopic inflammation. * **ANCA vs. ASCA:** Remember that **p-ANCA** is more commonly associated with Ulcerative Colitis [1], while **ASCA** (Anti-Saccharomyces cerevisiae antibodies) is associated with Crohn’s disease. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, pp. 807-809.

Question 139: Which of the following is a risk factor for the development of gastric carcinoma?

A. Blood group O
B. Duodenal ulcer
C. Intestinal hyperplasia
D. Intestinal metaplasia type III (Correct Answer)

Explanation: **Explanation:** Gastric adenocarcinoma (specifically the intestinal type) follows a well-defined multi-step progression known as the **Correa Pathway**: Chronic gastritis → Atrophic gastritis → Intestinal metaplasia → Dysplasia → Adenocarcinoma [1]. **1. Why Option D is Correct:** Intestinal metaplasia (IM) occurs when the gastric mucosa is replaced by epithelium resembling the small or large intestine [2]. It is classified into three types. **Type III (Incomplete/Colonic metaplasia)** is characterized by the presence of sulfomucins and a lack of absorptive cells. It carries the **highest risk** of malignant transformation and is considered a definitive pre-cancerous lesion. **2. Why Other Options are Incorrect:** * **Option A (Blood group O):** This is associated with an increased risk of **Peptic Ulcer Disease (Duodenal ulcers)**. Conversely, **Blood group A** is the genetic risk factor associated with Gastric Carcinoma. * **Option B (Duodenal ulcer):** Patients with duodenal ulcers generally have high acid output, which is actually "protective" against gastric cancer. Gastric cancer is more commonly associated with **Gastric ulcers** occurring in a background of atrophic gastritis and hypochlorhydria. * **Option C (Intestinal hyperplasia):** This is a distractor term. The pathological precursor is **metaplasia** (change in cell type) and **dysplasia** (disordered growth), not simple hyperplasia [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Lauren Classification:** Divides gastric cancer into **Intestinal type** (associated with H. pylori and metaplasia) and **Diffuse type** (associated with *CDH1* mutations and Signet ring cells) [3]. * **Nitrosamines:** Dietary amines found in smoked/salted foods are potent carcinogens for gastric cancer. * **Virchow’s Node:** Left supraclavicular lymphadenopathy indicating metastasis. * **Sister Mary Joseph Nodule:** Periumbilical metastasis, common in intestinal-type gastric cancer. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, pp. 777-778. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Alimentary System Disease, pp. 354-355. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, p. 779.

Question 140: A 55-year-old woman presents with fatigue and malaise which has been worsening over the last 2 months. She also noticed loss of appetite and early satiety. Evaluation finds an ulcerative mass located along the lesser curvature of the stomach along with bilateral ovarian masses. Which of the following is this patient most likely to have?

A. Krukenberg tumor (Correct Answer)
B. Gastric leiomyosarcoma
C. Meig syndrome
D. Ovarian dysgerminoma

Explanation: **Explanation:** The clinical presentation of a gastric mass (ulcerative lesion on the lesser curvature) associated with bilateral ovarian masses in an older woman is a classic description of a **Krukenberg tumor**. **1. Why the correct answer is right:** A Krukenberg tumor refers to a metastatic signet-ring cell carcinoma of the ovary, where the primary site is most commonly the **stomach** (usually the pylorus or lesser curvature) [2]. The spread occurs via hematogenous or lymphatic routes (retrograde lymphatic spread). Histologically, these tumors are characterized by **mucin-secreting signet-ring cells** and a dense desmoplastic stroma [2]. A key diagnostic feature is that these metastases are almost always **bilateral** [1]. **2. Why the incorrect options are wrong:** * **Gastric leiomyosarcoma:** This is a rare mesenchymal tumor. While it can cause gastric symptoms, it does not typically metastasize to the ovaries bilaterally. * **Meig syndrome:** This is a triad of a benign ovarian tumor (usually a **fibroma**), ascites, and pleural effusion. It is not associated with primary gastric malignancy. * **Ovarian dysgerminoma:** This is a germ cell tumor typically seen in younger women (2nd–3rd decade). It is the female counterpart of a seminoma and is not associated with gastric cancer. **High-Yield Clinical Pearls for NEET-PG:** * **Primary Source:** Stomach (most common), followed by colon, breast, and appendix. * **Histology:** Signet-ring cells (nucleus pushed to the periphery by a large mucin vacuole) [2]. * **Stain:** Positive for **PAS** and **Mucicarmine**. * **Sister Mary Joseph Nodule:** Another metastatic manifestation of gastric cancer, presenting as a palpable nodule at the umbilicus. * **Virchow’s Node:** Left supraclavicular lymphadenopathy, often the first sign of abdominal malignancy. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Female Genital Tract, pp. 1026-1028. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, p. 779.

Practice by Chapter

Oral Cavity and Esophageal Pathology

Practice Questions

Gastritis and Peptic Ulcer Disease

Practice Questions

Inflammatory Bowel Disease

Practice Questions

Malabsorption Syndromes

Practice Questions

Vascular Disorders of Intestine

Practice Questions

Diverticular Disease

Practice Questions

Intestinal Obstruction

Practice Questions

Gastrointestinal Infections

Practice Questions

Polyps and Neoplasms

Practice Questions

Appendiceal Pathology

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free